Paola Alberti

MD, PhD in preclinical neuroscience, board in Neurology.
Her expertise is related to peripheral neuropathies, especially Chemotherapy-induced peripheral neurotoxicity (CIPN). She is in charge of both clinical and preclinical CIPN research projects.
At a preclinical level she has developed a line of research that applies morpho-functional techniques to study axonal damage mechanisms, with particular attention to ion channel dysfunctions.
To this end she learnt nerve excitability testing from Prof Hugh Bostock, PhD in London (UCL). At a clinical level she is Principal Investigator of national and international studies aimed at investigating various clinical and epidemiological aspects of CIPN: ICAVS (NCT04633655), CIPN COST (NCT04986891) and NEUPER study (NCT05088681).
She was a visiting research fellow at Johns Hopkins University (2015) and the University of Maryland (2018). She is currently a member of the board of the Italian Association of Peripheral Neuropathies (ASNP), vice chair of the junior committee of the Peripheral Nerve Society (PNS) and represented of this committee within the Toxic Neuropathy Consortium of PNS, chair of the neurological complication study group of the Multinational Association for Supportive Care in Cancer (MASCC).
She is the author of 82 publications in international journals (H-index: 33 on Scopus).